Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems

NCT07296263 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Intra-axial Tumors
Extra-axial Tumors
Infection/Inflammatory Lesions

Interventions

DEVICE: Portable MRI (pMRI)
DRUG: Gadolinium-Based Contrast Agent (GBCA)

Sponsor

Hyperfine